CAC Stock Analysis: Camden National | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 923m USD | 12M Return: 30.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.21M
EPS Trend: 72.9%
Qual. Beats: 0
Rev. Trend: 99.0%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Camden National Corporation (NASDAQ: CAC) is a Maine-based bank holding company founded in 1875 that operates through its primary subsidiary, Camden National Bank. As a regional bank with a small market capitalization of approximately $871 million, the company provides commercial and consumer banking products and services across the United States, serving consumer, institutional, municipal, non-profit, and commercial customers.
The companys core banking operations include accepting various deposit products such as checking, savings, time, brokered deposits, and CDARS (Certificate of Deposit Account Registry System) deposits. Its lending portfolio spans non-owner-occupied and owner-occupied commercial real estate loans, commercial loans, residential real estate loans for one- to four-family residences, and consumer and home equity loans. Like most regional banks, Camden National primarily earns revenue through the net interest spread between its loan products and deposit funding, supplemented by non-interest income from fee-based services.
Beyond traditional banking, Camden National offers wealth management and financial services through brokerage, insurance, retirement planning, estate planning, mutual funds, annuities, and strategic asset management accounts. The company also provides fiduciary, asset management, investment advisory, financial planning, and trustee services, creating a diversified revenue stream typical of community banks seeking to deepen customer relationships and reduce reliance on interest-rate-driven earnings.
- Net interest margin expands on rising loan yields
- Commercial real estate portfolio faces elevated credit risk
- Deposit costs pressure margins as competition intensifies
| Net Income: 79.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.57 > 1.0 |
| NWC/Revenue: -121.0% < 20% (prev -1.67k%; Δ 1.55k% < -1%) |
| CFO/TA 0.01 > 3% & CFO 82.9m > Net Income 79.7m |
| Net Debt (540.3m) to EBITDA (87.9m): 6.15 < 3 |
| Current Ratio: 0.16 > 1.5 & < 3 |
| Outstanding Shares: last quarter (17.0m) vs 12m ago -0.43% < -2% |
| Gross Margin: 65.41% > 18% (prev 58.09%; Δ 7.32% > 0.5%) |
| Asset Turnover: 5.14% > 50% (prev 4.41%; Δ 0.72% > 0%) |
| Interest Coverage Ratio: 0.70 > 6 (EBIT TTM 79.6m / Interest Expense TTM 113.9m) |
| A: -0.06 (Total Current Assets 82.5m - Total Current Liabilities 515.3m) / Total Assets 6.96b |
| B: 0.08 (Retained Earnings 559.9m / Total Assets 6.96b) |
| C: 0.01 (EBIT TTM 79.6m / Avg Total Assets 6.96b) |
| D: 0.11 (Book Value of Equity 710.0m / Total Liabilities 6.25b) |
| Altman-Z'' = 0.05 = B |
As of July 08, 2026, the stock is trading at USD 53.93 with a total of 75,753 shares traded. Over the past week, the price has changed by -0.06%, over one month by +6.33%, over three months by +10.81% and over the past year by +30.23%.
Current recommended Stop Loss: 50.10 (which is 7.1% or 2.4 ATR below the current price).
Camden National has received a consensus analysts rating of 3.25. Therefore, it is recommended to hold CAC.
- StrongBuy: 0
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 53.3 | -1.3% |
P/E Trailing = 11.6128
P/E Forward = 10.8932
P/S = 3.743
P/B = 1.3003
Revenue TTM = 357.8m USD
EBIT TTM = 79.6m USD
EBITDA TTM = 87.9m USD
Long Term Debt = 62.6m USD (from longTermDebt, last quarter)
Short Term Debt = 515.3m USD (from shortTermDebt, last quarter)
Debt = 602.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 540.3m USD (calculated: Debt 602.7m - CCE 62.5m)
Enterprise Value = 1.46b USD (923.2m + Debt 602.7m - CCE 62.5m)
Interest Coverage Ratio = 0.70 (Ebit TTM 79.6m / Interest Expense TTM 113.9m)
EV/FCF = 18.97x (Enterprise Value 1.46b / FCF TTM 77.2m)
FCF Yield = 5.27% (FCF TTM 77.2m / Enterprise Value 1.46b)
FCF Margin = 21.56% (FCF TTM 77.2m / Revenue TTM 357.8m)
Net Margin = 22.28% (Net Income TTM 79.7m / Revenue TTM 357.8m)
Gross Margin = 65.41% ((Revenue TTM 357.8m - Cost of Revenue TTM 123.8m) / Revenue TTM)
Gross Margin QoQ = 66.81% (prev 70.76%)
Tobins Q-Ratio = 0.21 (Enterprise Value 1.46b / Total Assets 6.96b)
Interest Expense / Debt = 18.89% (Interest Expense 113.9m / Debt 602.7m)
Taxrate = 20.73% (20.8m / 100.6m)
NOPAT = 63.1m (EBIT 79.6m * (1 - 20.73%))
Current Ratio = 0.16 (Total Current Assets 82.5m / Total Current Liabilities 515.3m)
Debt / Equity = 0.85 (Debt 602.7m / totalStockholderEquity, last quarter 710.0m)
Debt / EBITDA = 6.15 (Net Debt 540.3m / EBITDA 87.9m)
Debt / FCF = 7.00 (Net Debt 540.3m / FCF TTM 77.2m)
Total Stockholder Equity = 683.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.14% (Net Income 79.7m / Total Assets 6.96b)
RoE = 11.66% (Net Income TTM 79.7m / Total Stockholder Equity 683.8m)
RoCE = 10.66% (EBIT 79.6m / Capital Employed (Equity 683.8m + L.T.Debt 62.6m))
RoIC = 0.91% (NOPAT 63.1m / Invested Capital 6.94b)
WACC = 11.18% (E(923.2m)/V(1.53b) * Re(8.70%) + D(602.7m)/V(1.53b) * Rd(18.89%) * (1-Tc(0.21)))
Discount Rate = 8.70% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 55.21 | Cagr: 6.86%
[DCF] Terminal Value 69.38% ; FCFF base≈61.3m ; Y1≈70.2m ; Y5≈103.4m
[DCF] Fair Price = 29.28 (EV 1.04b - Net Debt 540.3m = Equity 495.3m / Shares 16.9m; r=11.18% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 72.94 | EPS CAGR: 8.25% | SUE: 0.32 | # QB: 0
Revenue Correlation: 98.97 | Revenue CAGR: 18.43% | SUE: 0.33 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.28 | Chg30d=-0.39% | Revisions=-57% | Analysts=4
EPS next Quarter (2026-09-30): EPS=1.35 | Chg30d=-0.18% | Revisions=-29% | Analysts=4
EPS current Year (2026-12-31): EPS=5.35 | Chg30d=-0.14% | Revisions=-40% | GrowthEPS=+21.9% | GrowthRev=+6.1%
EPS next Year (2027-12-31): EPS=5.81 | Chg30d=-0.30% | Revisions=+0% | GrowthEPS=+8.5% | GrowthRev=+9.6%
[Analyst] Revisions Ratio: -53% (up=2, down=10)